iHealth-T2D is a multicentre, cluster randomised clinical trial on Type 2 Diabetes (T2D) in South Asian population. The study brings together institutions from India, Pakistan and Sri Lanka in order to provide evidence about the implementation of lifestyle modifications and health promotion for prevention of T2D.

Type-2 diabetes is the fifth leading cause of death worldwide and a major contributor to development of coronary heart disease, stroke, peripheral vascular disease and end-stage renal failure. Studies in European populations show that intensive lifestyle modifications, involving physical activity, dietary change and weight loss is associated with reduction in the incidence of T2D amongst people at high risk.

Quick Links